Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Clermont-Ferrand
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 to 55 years
Migraine diagnosis for \>1 year
Meeting ICHD-3 (International Classification of Headache Disorders 3rd edition, code 1.1) diagnostic criteria
Effective contraception for females of childbearing potential
Sufficient cooperation and understanding to comply with trial requirements
Provided informed consent after receiving complete study information
Enrolled in the French Social Security system
You may not be if
Hypersensitivity: Known allergy to any component of the investigational product(s), salicylates, or camphor.
Substance abuse: Current drug dependence or abuse (investigator's judgment).
Pregnancy/breastfeeding: Pregnant or lactating women.
Concurrent trials: Participation in another clinical trial, ongoing exclusion period, or receipt of \>€6000 in trial-related compensation in the past 12 months.
Legal protections: Under legal guardianship, curatorship, or deprivation of liberty.
Medical incompatibility: Any condition deemed unsafe for participation (investigator's assessment).
Significant medical history: Relevant comorbidities or antecedents (investigator's discretion).
Clareo Health | Evaluation of MIG-SPRAY Treatment on Migraine
